✦ LIBER ✦

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

✍ Scribed by Pondal, M.; Marras, C.; Miyasaki, J.; Moro, E.; Armstrong, M. J.; Strafella, A. P.; Shah, B. B.; Fox, S.; Prashanth, L. K.; Phielipp, N.; Lang, A. E.

Book ID: 115464125
Publisher: BMJ Publishing Group
Year: 2012
Tongue: English
Weight: 145 KB
Volume: 84
Category: Article
ISSN: 0022-3050
DOI: 10.1136/jnnp-2012-302684

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhalant withdrawal as a clinically sign

Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder

✍ Brian E. Perron; Matthew O. Howard; Michael G. Vaughn; Christopher N. Jarman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Chanarin-Dorfman Syndrome: Clinical Feat

Chanarin-Dorfman Syndrome: Clinical Features of a Rare Lipid Metabolism Disorder

✍ Mukadder Ayse Selimoglu; Mukaddes Esrefoglu; Mehmet Gul; Serdal Gungor; Cigdem Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

Clinical use of dopamine transporter ima

Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use

✍ Giovanni Lucignani 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 98 KB

Clinical failure of botulinum toxin A in

Clinical failure of botulinum toxin A in movement disorders

✍ Rodolfo Savica; Brandon R. Grossardt; James H. Bower; Bryan T. Klassen; Joseph Y 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Clinical features of malignant syndrome

Clinical features of malignant syndrome in Parkinson's disease and related neurological disorders

✍ Toshihide Harada; Kyoko Mitsuoka; Rumi Kumagai; Yoshio Murata; Yumiko Kaseda; Hi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Profile of patients enrolled in a new mo

Profile of patients enrolled in a new movement disorder clinic

✍ Dr. Eric Siemers; V. Reddy 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

To assess the need for a regional expertise in movement disorders, the numbers of patients, clinic visits, and medication changes for a new movement disorder clinic were recorded. During 3 1/2 years, 355 patients were seen, with 1,329 clinic visits. Idiopathic Parkinson's disease was the most common